Latest News

Blocking key enzyme minimizes stroke injury, research finds

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, research suggests. The development of a Cdk5 inhibitor as an acute neuroprotective therapy has the potential to reduce stroke injury, researchers report.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Trust your aha! moments: Experiments show they're probably right

  • Scientists use synthetic gene and magnets to alter behavior of mice, fish

  • Teen girls see big drop in chemical exposure with switch in cosmetics

  • Female traders can reduce market crashes, expert says

  • Toxic byproduct of hemoglobin could provide clues for cerebral hemorrhage and Creutzfeldt-Jakob Disease

  • Clinician communication reduced distress related to the detection of incidental nodules

  • Talk about yourself on social media?

  • New mothers with postpartum psychiatric disorders face increased risk of suicide, study shows

  • Combining two techniques to 'rewire' the brain may improve arm, hand movement for stroke survivors

  • Scientists map roots of premeditated, violent 'intent' in animal brain

  •